Ellex Medical Lasers Limited announced the resignation of Mr. Malcolm Plunkett as a Director of the Company. Throughout his four and a half year tenure as a Director, Mr. Plunkett has been a full time executive in the business responsible for research and development and has made a significant contribution to the business. He will continue in this executive role concentrating on bringing the 2RT project through to market release and managing the business's research portfolio.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.255 AUD | 0.00% | +6.25% | +6.25% |
Jul. 08 | Nova Eye Medical's Glaucoma Division Sees 37% Rise in Sales for Fiscal 2024 | MT |
Mar. 15 | Nova Eye Medical Completes Retail Entitlement Offer | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.25% | 39.37M | |
+1.15% | 205B | |
+4.69% | 179B | |
+31.83% | 158B | |
+33.39% | 113B | |
+2.51% | 64.93B | |
+22.99% | 56.51B | |
-4.03% | 46.36B | |
-8.60% | 37.07B | |
+2.35% | 36.12B |
- Stock Market
- Equities
- EYE Stock
- News Nova Eye Medical Limited
- Ellex Medical Lasers Limited Announces the Resignation of Malcolm Plunkett as A Director